ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,861Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 680

$1.17M Total Retail Price of All Prescriptions

Rank: 51 out of 680

756 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 756 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 756 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 842 587 1 3
METFORMIN HCL 523 299 2 8
LEVOTHYROXINE SODIUM 514 290 3 2
LISINOPRIL 451 295 4 5
AMLODIPINE BESYLATE 435 311 5 1
OMEPRAZOLE 410 253 6 7
FUROSEMIDE 278 168 7 6
HYDROCHLOROTHIAZIDE 251 150 8 9
METOPROLOL SUCCINATE 250 187 9 13
FENOFIBRATE 248 161 10 66
ATORVASTATIN CALCIUM 240 146 11 11
WARFARIN SODIUM 238 210 12 20
JANUVIA 231 143 13 60
GLIMEPIRIDE 228 141 14 29
ZOLPIDEM TARTRATE 222 97 15 17
HYDROCODONE-ACETAMINOPHEN 218 118 S3 16 4
METOPROLOL TARTRATE 204 156 17 12
NEXIUM 197 101 18 16
TRAMADOL HCL 188 112 19 18
BENICAR HCT 179 134 20 150
TRAZODONE HCL 178 75 21 48
AZITHROMYCIN 174 111 22 42
PRAVASTATIN SODIUM 172 132 23 10
ATENOLOL 165 124 24 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 163 93 25 37
BENICAR 149 101 26 131
GABAPENTIN 145 67 27 15
INSULIN SYRINGE 142 84 28 86
CRESTOR 136 69 29 25
LANTUS 134 78 30 49
FLUTICASONE PROPIONATE 127 74 31 41
CITALOPRAM HBR 127 85 31 22
LOVAZA 126 69 33 119
LOSARTAN POTASSIUM 113 75 34 21
LEVOCETIRIZINE DIHYDROCHLORIDE 97 65 35 216
ALENDRONATE SODIUM 96 74 36 32
PROAIR HFA 94 60 37 67
DIOVAN 93 74 38 31
DIGOXIN 88 65 39 58
PANTOPRAZOLE SODIUM 86 80 40 30
TAMSULOSIN HCL 86 86 40 34
POTASSIUM CHLORIDE 85 48 42 14
RANITIDINE HCL 85 55 42 56
TRIBENZOR 84 55 44 321
BYSTOLIC 83 73 45 79
PAROXETINE HCL 83 37 45 76
ALLOPURINOL 83 65 45 33
COMBIVENT 82 59 48 168
DONEPEZIL HCL 82 82 48 27
MELOXICAM 81 52 50 24
ESCITALOPRAM OXALATE 81 42 50 45
LOVASTATIN 77 57 52 44
LEVOFLOXACIN 74 38 53 97
AZOR 74 54 53 278
WELCHOL 70 0 55 223
TRICOR 70 45 55 98
AMLODIPINE BESYLATE-BENAZEPRIL 70 49 55 43
CIPROFLOXACIN HCL 69 53 58 57
CLOPIDOGREL 66 28 59 26
BENAZEPRIL HCL 66 51 59 40
NAMENDA 65 65 61 35
SERTRALINE HCL 65 41 61 28
CLONAZEPAM 64 45 63 190
LANTUS SOLOSTAR 63 45 64 84
SYNTHROID 63 30 64 38
CARVEDILOL 61 38 66 23
MECLIZINE HCL 60 52 67 103
PEN NEEDLE 59 32 68 122
PLAVIX 58 46 69 39
KLOR-CON M20 58 37 69 61
LYRICA 58 34 69 77
QUETIAPINE FUMARATE 58 18 69 64
GEMFIBROZIL 57 30 73 106
ENALAPRIL MALEATE 57 54 73 65
TRADJENTA 56 46 75 301
VESICARE 56 12 75 176
FLUOXETINE HCL 56 27 75 74
BUPROPION XL 55 24 78 161
CYMBALTA 54 29 79 46
ADVAIR DISKUS 54 34 79 53
ZETIA 53 22 81 87
GLYBURIDE 53 49 R 81 85
LANSOPRAZOLE 52 31 83 184
CYCLOBENZAPRINE HCL 51 0 R 84 81
VERAPAMIL ER 50 50 85 100
ROPINIROLE HCL 50 22 85 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.